A federal judicial panel has transferred nearly 130 lawsuits to New Jersey brought over Janssen Pharmaceuticals’ pharmaceutical drug Elmiron.

The U.S. Judicial Panel on Multidistrict Litigation appointed U.S. District Judge Brian Martinotti to oversee the lawsuits, which allege that Elmiron, used to treat chronic bladder infection called interstitial cystitis, causes eye problems. Plaintiffs lawyers initially had split over whether the cases should go to New Jersey or Pennsylvania.